Lamberto Andreotti

Type: Person
Name: Lamberto Andreotti
First reported Feb 05 2014 - Updated Feb 05 2014 - 1 reports

Product Positioning 2.0

In 2009, marketing partners Eli Lilly and Daichii Sankyo were preparing to launch their new blood thinner Effient (prasugrel) which appeared to have greater efficacy than the market leader Plavix, the world's second best selling product, sold by Bristol-Myers ... [Published Pharmaceutical Executive - Feb 05 2014]
First reported Jan 27 2014 - Updated Jan 27 2014 - 1 reports

Bristol-Myers Squibb net falls by 21.5% in Q4

Bristol-Myers Squibb Company has posted lower net profit of US$ 726 million during the fourth quarter ended December 2013 as against $925 million in the corresponding period of last year. Its net product sales increased by 6.9 per cent to $3,298 million ... [Published PharmaBiz - Jan 27 2014]
First reported Jan 20 2014 - Updated Jan 20 2014 - 1 reports

J.P. Morgan: Pharma’s Agenda for 2014

Presenters at the 32 nd annual J.P. Morgan Healthcare Conference talked up value-based pricing, emerging market strategies, complex generics and new technology, from bedside devices and genetic sequencers to first-in-class mechanisms of action. Company ... [Published Pharmaceutical Executive - Jan 20 2014]
First reported Dec 11 2013 - Updated Dec 11 2013 - 1 reports

The Best Biotech CEO of 2013 is...

The Best Biotech CEO of 2013 is Bob Hugin of Celgene . In an incredibly strong year for all the big-cap biotech stocks, Hugin steered Celgene to the top of the heap. The multiple myeloma drug Revlimid remains Celgene's most important profit driver, but ... [Published The Street Latest - Dec 11 2013]
First reported Dec 04 2013 - Updated Dec 04 2013 - 1 reports

Best Biotech CEO of 2013: Your Vote Counts

NEW YORK (TheStreet) -- Stock performance has always been an important measuring stick for the Biotech CEO of the Year award. But in a year when seemingly every bio-pharma company -- even the worst of the bunch -- managed to deliver outsized returns, ... [Published The Street Latest - Dec 04 2013]

More Content

All (5) | News (5) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Product Positioning 2.0 [Published Pharmaceutical Executive - Feb 05 2014]
Bristol-Myers Squibb net falls by 21.5% in Q4 [Published PharmaBiz - Jan 27 2014]
J.P. Morgan: Pharma’s Agenda for 2014 [Published Pharmaceutical Executive - Jan 20 2014]
The Best Biotech CEO of 2013 is... [Published The Street Latest - Dec 11 2013]
Best Biotech CEO of 2013: Your Vote Counts [Published The Street Latest - Dec 04 2013]
1
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.